Review articlePublished 3 Sep 2021
The role of gut microbiome in cardiometabolic disease.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The study of the human microbiota has recently emerged as an area of utmost importance. The human gut microbiome consists of trillions of microorganisms that outnumber human cells and play a vital role in host metabolism. Obesity is a risk factor for cardiometabolic disease (CMD), which includes type 2 diabetes mellitus (T2DM), dyslipidemia, hypertension, cardiovascular disease and non-alcoholic fatty liver disease (NAFLD). Recent studies have shown a connotation between microbiota and CMD. Studies have established that the gut microbiota is one of the crucial factors, which influence the metabolic state of the host and acts as a propeller for the disease. In this review, we focus on the recent findings on the dysbiosis of gut microbiota and CMD pathogenesis and future therapeutic intervention involving gut microbiome manipulation.
Subjects
Nursing & HealthcareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives of General Internal Medicine
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Ashwini Kumar Ray”
- BylineArticles whose byline prints “Urvinder S. Kaur”
- BylineArticles whose byline prints “Jyoti Gupta”
- BylineArticles whose byline prints “Alka Yadav”
- BylineArticles whose byline prints “Tannu Bhagchandani”
- BylineArticles whose byline prints “Alok kumar singh”
- BylineArticles whose byline prints “Shalimar”
- BylineArticles whose byline prints “Ravi Tandon”
